Fund shareholders of Harmony Biosciences Holdings Inc
ISIN US4131971040 · United States
- Fund shareholders
- 321
- Of which ETFs
- 93 228 other funds
- Value held
- 650.8M $ 20.7M SEK · 135.4K €
- Share of capital
- 38.9 % of 58.2M shares on Jul 31, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 255 | 8K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 226 | 6.3K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 2x Strategy Fund Rydex Dynamic Funds | 217 | 6.1K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SMALL-CAP GROWTH PROFUND ProFunds | 215 | 6.7K $ | 0.15 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Innovator U.S. Small Cap Managed 10 Buffer ETF Innovator ETFs Trust | 198 | 6.2K $ | 0.08 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Wilshire 5000 Index Fund Wilshire Mutual Funds Inc | 168 | 4.7K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP ULTRA SMALL CAP ProFunds | 146 | 4.1K $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP SMALL CAP ProFunds | 111 | 3.1K $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 Fund Rydex Series Funds | 100 | 2.8K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 80 | 2.5K $ | 0.03 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 76 | 2.1K $ | 0.07 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 60 | 1.7K $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) 1500 Momentum Tilt ETF SPDR SERIES TRUST | 59 | 1.7K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Hedge Replication ETF ProShares Trust | 45 | 1.3K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Goldman Sachs MSCI World Private Equity Return Tracker ETF Goldman Sachs ETF Trust | 30 | 856.2 $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Federated Hermes Global Allocation Fund Federated Hermes Global Allocation Fund | 21 | 599.3 $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Avantis Total Equity Markets ETF American Century ETF Trust | 15 | 428.1 $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 14 | 399.6 $ | 0.04 % | 0.00 % | as of Feb 28, 2026 ↗ |
| E*TRADE No Fee Total Market Index Fund E Trade Trust | 12 | 375.1 $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 11 | 308.1 $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| GVC GAESCO ZEBRA US SMALL CAPS LOW POPULARITY, FI GVC GAESCO GESTIÓN, SGIIC, S.A. | 135.4K € | 1.03 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Abacus FCF Small Cap Leaders ETF Abacus FCF ETF Trust | 3.29 % | as of Apr 30, 2026 ↗ |
| Invesco Pharmaceuticals ETF Invesco Exchange-Traded Fund Trust | 3.25 % | as of Apr 30, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF SPDR SERIES TRUST | 1.87 % | as of Mar 31, 2026 ↗ |
| PROFUND VP PHARMACEUTICALS ProFunds | 1.79 % | as of Mar 31, 2026 ↗ |
| AUER GROWTH Unified Series Trust | 1.57 % | as of Feb 28, 2026 ↗ |
| Direxion Daily Pharmaceutical & Medical Bull 3X Shares Direxion Shares ETF Trust | 1.45 % | as of Apr 30, 2026 ↗ |
| PHARMACEUTICALS ULTRASECTOR PROFUND ProFunds | 1.43 % | as of Apr 30, 2026 ↗ |
| Royce Capital Fund - Small-Cap Portfolio ROYCE CAPITAL FUND | 1.26 % | as of Mar 31, 2026 ↗ |
| Royce Small-Cap Value Fund ROYCE FUND | 1.25 % | as of Mar 31, 2026 ↗ |
| Virtus Biotech Etf ETFis Series Trust I | 1.23 % | as of Apr 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 318 | +11 | 22,585,485 | +7.7 % |
| 2026Q1 | 307 | +7 | 20,978,273 | -1.0 % |
| 2025Q4 | 300 | +1 | 21,190,246 | -1.3 % |
| 2025Q3 | 299 | 0 | 21,466,896 | +2.7 % |
| 2025Q2 | 299 | +18 | 20,894,573 | -8.2 % |
| 2025Q1 | 281 | +7 | 22,757,078 | +30.0 % |
| 2024Q4 | 274 | +4 | 17,505,514 | -10.0 % |
| 2024Q3 | 270 | +3 | 19,445,293 | -1.9 % |
| 2024Q2 | 267 | +7 | 19,827,777 | +7.4 % |
| 2024Q1 | 260 | +11 | 18,455,848 | +7.0 % |
| 2023Q4 | 249 | 17,254,170 |
Institutional managers
301 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| BlackRock, Inc. | 7,070,035 | 198M $ | as of Mar 31, 2026 |
| FMR LLC | 3,157,639 | 88.4M $ | as of Mar 31, 2026 |
| AMERICAN CENTURY COMPANIES INC | 2,105,179 | 59M $ | as of Mar 31, 2026 |
| DIMENSIONAL FUND ADVISORS LP | 2,076,510 | 58.2M $ | as of Mar 31, 2026 |
| LSV ASSET MANAGEMENT | 2,025,143 | 56.7K $ | as of Mar 31, 2026 |
| SG Americas Securities, LLC | 2,018,174 | 56.5K $ | as of Mar 31, 2026 |
| STATE STREET CORP | 1,784,362 | 50M $ | as of Mar 31, 2026 |
| ARMISTICE CAPITAL, LLC | 1,624,000 | 45.5M $ | as of Mar 31, 2026 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1,382,113 | 38.7M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 1,322,720 | 37.1M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 1,239,207 | 34.7M $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 1,077,371 | 30.2M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 1,031,018 | 28.9M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 954,359 | 26.7M $ | as of Mar 31, 2026 |
| JPMORGAN CHASE & CO | 823,513 | 22.2M $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 733,443 | 20.5M $ | as of Mar 31, 2026 |
| AQR CAPITAL MANAGEMENT LLC | 716,246 | 20.1M $ | as of Mar 31, 2026 |
| Invesco Ltd. | 628,247 | 17.6M $ | as of Mar 31, 2026 |
| Trexquant Investment LP | 594,850 | 16.7M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 585,623 | 16.4M $ | as of Mar 31, 2026 |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 567,115 | 15.9M $ | as of Mar 31, 2026 |
| BNP PARIBAS FINANCIAL MARKETS | 545,188 | 15.3M $ | as of Mar 31, 2026 |
| NOMURA HOLDINGS INC | 520,947 | 14.6M $ | as of Mar 31, 2026 |
| venBio Partners LLC | 489,194 | 13.7M $ | as of Mar 31, 2026 |
| Man Group plc | 461,898 | 12.9M $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Fund shareholders of Harmony Biosciences Holdings Inc". https://titelia.com/en/stocks/harmony-biosciences-holdings-inc-US4131971040